Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: A multicenter study

Radiotherapy and Oncology

Volumn 102, Issue 2, 2012, Pages 246-250

  Li, Xiaolin ^a   Zhang, Huaqi ^a   Xing, Ligang ^a   Ma, Honglian ^b   Xie, Peng ^a   Zhang, Lin ^c   Xu, Xiangying ^d   Yue, Jinbo ^a   Sun, Xindong ^a   Hu, Xudong ^e   Chen, Ming ^b   Xu, Wengui ^f   Chen, Lusheng ^e   Yu, Jinming ^a,e  

^a Department of Radiation Oncology   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c SHANDONG UNIVERSITY   (China)

^d HARBIN MEDICAL UNIVERSITY   (China)

^e SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^f TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

18F FDG PET CT; Lymph node; NSCLC; SBRT; Stage I

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MULTICENTER STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84857626889     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.10.016     Document Type: Article

References (30)

1. R.C. McGarry, G. Song, and P. des Rosiers Observation-only management of early stage, medically inoperable lung cancer: poor outcome Chest 121 2002 1155 1158
2. D.J. Raz, J.A. Zell, and S.H. Ou Natural history of stage I non-small cell lung cancer: implications for early detection Chest 132 2007 193 199
3. C.J. Haasbeek, B.J. Slotman, and S. Senan Radiotherapy for lung cancer: clinical impact of recent technical advances Lung Cancer 64 2009 1 8
4. A. Takeda, N. Yokosuka, and T. Ohashi The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT) Radiother Oncol 101 2011 291 297
5. N. Mohammed, I.S. Grills, C.Y. Wong, A.P. Galerani, K. Chao, and R. Welsh Radiographic and metabolic response rates following image-guided stereotactic radiotherapy for lung tumors Radiother Oncol 99 2011 18 22
6. J.P. Grutters, A.G. Kessels, and M. Pijls-Johannesma Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small-cell lung cancer: a meta-analysis Radiother Oncol 95 2010 32 40
7. F.J. Lagerwaard, C.J. Haasbeek, and E.F. Smit Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 685 692
8. S.J. Kim, Y.K. Kim, and I.J. Kim Limited prognostic value of dual time point F-18 FDG PET/CT in patients with early stage (stages I & II) non-small cell lung cancer (NSCLC) Radiother Oncol 98 2011 105 108
9. L.J. Vanuytsel, J.F. Vansteenkiste, and S.G. Stroobants The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer Radiother Oncol 55 2000 317 324
10. 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients Cancer 109 2007 1068 1077
11. T. Beyer, D.W. Townsend, and T. Brun A combined PET/CT scanner for clinical oncology J Nucl Med 41 2000 1369 1379
12. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? J Nucl Med 48 2007 1761 1766
13. C.F. Mountain, and C.M. Dresler Regional lymph node classification for lung cancer staging Chest 111 1997 1718 1723
14. H. Onishi, H. Shirato, and Y. Nagata Stereotactic body radiotherapy (SBRT) for operable stage i non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 81 2011 1352 1358
15. I.S. Grills, V.S. Mangona, and R. Welsh Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer J Clin Oncol 28 2010 928 935
16. F. Alongi, P. Ragusa, and P. Montemaggi Combining independent studies of diagnostic fluorodeoxyglucose positron-emission tomography and computed tomography in mediastinal lymph node staging for non-small cell lung cancer Tumori 92 2006 327 333
17. G.A. Silvestri, M.K. Gould, and M.L. Margolis Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition) Chest 132 2007 178 201
18. B.T. Kim, K.S. Lee, and S.S. Shim Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT-a prospective study Radiology 241 2006 501 509
19. N. Al-Sarraf, K. Gately, and J. Lucey Clinical implication and prognostic significance of standardised uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases Eur J Cardiothorac Surg 34 2008 892 897
20. H. Van Tinteren, O.S. Hoekstra, and E.F. Smit Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multi-centre randomised trial Lancet 359 2002 1388 1393
21. R.C. Viney, M.J. Boyer, and M.T. King Randomized controlled clinical trial of the role of positron emission tomography in the management of stages I and II non-small-cell lung cancer J Clin Oncol 22 2004 2357 2362
22. M. MacManus, U. Nestle, and K.E. Rosenzweig Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007 Radiother Oncol 91 2009 85 94
23. A. Abramyuk, S. Tokalov, and K. Zöphel Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer? Radiother Oncol 91 2009 399 404
24. M. Wanet, J.A. Lee, and B. Weynand Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: a comparison with threshold-based approaches, CT and surgical specimens Radiother Oncol 98 2011 117 125
25. M.A. Farrell, H.P. McAdams, and J.E. Herndon Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease Radiology 215 2000 886 890
26. C. Turkmen, K. Sonmezoglu, and A. Toker The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high Clin Nucl Med 32 2007 607 612
27. T. Kasai, K. Motoori, and T. Horikoshi Dual-time point scanning of integrated FDG PET/CT for the evaluation of mediastinal and hilar lymph nodes in non-small cell lung cancer diagnosed as operable by contrast-enhanced CT Eur J Radiol 75 2010 143 146
28. B. Fischer, U. Lassen, and J. Mortensen Preoperative staging of lung cancer with combined PET-CT N Engl J Med 361 2009 32 39
29. 18F-fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study Radiother Oncol 98 2011 109 116
30. F.C. Detterbeck, M.A. Jantz, and M. Wallace Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 2007 202S 220S